About TFChem
TFChem is a company based in Rouen (France) founded in 2007. TFChem operates in a competitive market with competitors including GlyTech, Iceni Glycoscience, Echelon Biosciences, Avanti Polar Lipids and GlycoSpot, among others.
- Headquarter Rouen, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
CNRS
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TFChem
Investors in TFChem
TFChem has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include CNRS, University of Rouen Normandie and INSA Rouen Normandy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Multiple courses and degrees are offered in diversified academic streams.
|
Locked | Locked | Locked | |
|
Engineering courses are delivered by INSA Rouen Normandy center.
|
Locked | Locked | Locked |
Investor details for TFChem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TFChem
Investment portfolio details for TFChem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TFChem
Detailed financials for TFChem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tfchem Comparisons
Peer comparison for TFChem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TFChem
TFChem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GlyTech, Iceni Glycoscience, Echelon Biosciences, Avanti Polar Lipids and GlycoSpot, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Human-type Asp-linked glycans are supplied for research applications.
|
|
| Locked | Locked | Locked |
Glycoscience platform is provided for diagnostic and therapeutic applications.
|
|
| Locked | Locked | Locked |
Reagents and assays for lipid biology research are manufactured.
|
|
| Locked | Locked | Locked |
Phospholipids and lipids are manufactured for life science applications.
|
|
| Locked | Locked | Locked |
High-throughput enzyme screening solutions are developed and provided.
|
Detailed competitors of TFChem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tfchem
Complete news archive for TFChem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TFChem
TFChem was founded in 2007 and raised its 1st funding round 5 years after it was founded.
TFChem is headquartered in Rouen, France. It is registered at Rouen, Normandie, France.
TFChem was established in 2007 in Rouen, France, as a drug discovery entity within the biotechnology sector. Fluoride-modified carbohydrate compounds are developed for therapeutics addressing cancer, diabetes, cardiovascular diseases, pain, and inflammation. The GlycoMim platform is employed to enhance stability, bioavailability, and selectivity of these molecules. Collaborations with pharmaceutical firms are pursued for candidate advancement, while internal programs are operated. The company functions as a subsidiary of Sirona Biochem Corp.
TFChem's top competitors include GlyTech, Echelon Biosciences and Iceni Glycoscience.
TFChem has 5 investors. Key investors include CNRS, University of Rouen Normandie, INSA Rouen Normandy, Government of France, and Ministry of Economy, Finance and Industrial and Digital Sovereignty.